Diagnostics (Jun 2022)

Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer

  • Jonas Dohmen,
  • Alexander Semaan,
  • Makbule Kobilay,
  • Martin Zaleski,
  • Vittorio Branchi,
  • Anja Schlierf,
  • Karina Hettwer,
  • Steffen Uhlig,
  • Gunther Hartmann,
  • Jörg C. Kalff,
  • Hanno Matthaei,
  • Philipp Lingohr,
  • Stefan Holdenrieder

DOI
https://doi.org/10.3390/diagnostics12061413
Journal volume & issue
Vol. 12, no. 6
p. 1413

Abstract

Read online

Background: Despite the significance of colonoscopy for early diagnosis of colorectal adenocarcinoma (CRC), population-wide screening remains challenging, mainly because of low acceptance rates. Herein, exosomal (exo-miR) and free circulating microRNA (c-miR) may be used as liquid biopsies in CRC to identify individuals at risk. Direct comparison of both compartments has shown inconclusive results, which is why we directly compared a panel of 10 microRNAs in this entity. Methods: Exo-miR and c-miR levels were measured using real-time quantitative PCR after isolation from serum specimens in a cohort of 69 patients. Furthermore, results were compared to established tumor markers CEA and CA 19-9. Results: Direct comparison of exo- and c-miR biopsy results showed significantly higher microRNA levels in the exosomal compartment (p p < 0.05), while no c-miR showed this potential. Sensitivity and specificity can be further enhanced using combinations of multiple exosomal miRNAs. Conclusions: Exosomal microRNA should be considered as a promising biomarker in CRC for future studies. Nonetheless, results may show interference with common comorbidities, which must be taken into account in future studies.

Keywords